Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
2.140
-0.060 (-2.73%)
Mar 31, 2025, 9:30 AM EST - Market open

Perspective Therapeutics Market Cap

Perspective Therapeutics has a market cap or net worth of $158.47 million as of March 31, 2025. Its market cap has decreased by -49.56% in one year.

Market Cap
158.47M
Enterprise Value
-59.94M
1-Year Change
-49.56%
Ranking
Category
Stock Price
$2.14

Market Cap Chart

Since November 10, 2005, Perspective Therapeutics's market cap has increased from $49.80M to $158.47M, an increase of 218.21%. That is a compound annual growth rate of 6.15%.

History

DateMarket Cap% Change
Mar 28, 2025162.90M-24.44%
Dec 31, 2024215.60M91.13%
Dec 29, 2023112.80M221.37%
Dec 30, 202235.10M-36.18%
Dec 31, 202155.00M39.95%
Dec 31, 202039.30M-6.65%
Dec 31, 201942.10M108.42%
Dec 31, 201820.20M-8.18%
Dec 29, 201722.00M-31.03%
Dec 30, 201631.90M-38.18%
Dec 31, 201551.60M-35.58%
Dec 31, 201480.10M317.19%
Dec 31, 201319.20M-28.89%
Dec 31, 201227.00M41.36%
Dec 30, 201119.10M-28.20%
Dec 31, 201026.60M30.39%
Dec 31, 200920.40M343.48%
Dec 31, 20084.60M-90.09%
Dec 31, 200746.40M-40.28%
Dec 29, 200677.70M9.75%
Dec 30, 200570.80M42.17%
View and export this data all the way back to 2005. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 738.61B
UnitedHealth Group 472.03B
Johnson & Johnson 394.52B
AbbVie 363.15B
Novo Nordisk 305.46B
AstraZeneca 229.16B
Abbott Laboratories 226.88B
Merck & Co. 225.40B
Market Cap Rankings